Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on: January 29,2024

Study identifies biomarker that may predict treatment response to chemoimmunotherapy

by Keck School of Medicine of USCAn artist’s depiction of a T cell. Credit: NIAIDCutting-edge cancer treatments like immunotherapy are offering new hope for patients, often in combination with mo

Updated on:January 29,2024

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find

Updated on: January 22,2024

Most women diagnosed with early breast cancer can expect to become long-term survivors, say experts

byBritish Medical JournalCredit:BMJ(2023). DOI: 10.1136/bmj-2022-074684Most women diagnosed with early stage breast cancer today can expect to become long-term cancer survivors, find

Updated on:January 22,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on: March 14,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on:March 14,2024

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on: March 14,2024

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n

Updated on:March 14,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on: May 11,2024

Prostate cancer drug given initial 'no' for NHS in England

by Cancer Research UKCredit: Cancer Research UKA prostate cancer drug has been provisionally rejected as a first-line treatment on the NHS in England.The draft recommendation from the National In

Updated on:May 11,2024

Are older women being over-screened for cervical cancer?

byUniversity of Illinois at ChicagoCredit: CC0 Public DomainA new study published inJAMA Internal Medicinesuggests that women over the age of 65 may be undergoing unnecessary cervica

Updated on: December 28,2023

Are older women being over-screened for cervical cancer?

byUniversity of Illinois at ChicagoCredit: CC0 Public DomainA new study published inJAMA Internal Medicinesuggests that women over the age of 65 may be undergoing unnecessary cervica

Updated on:December 28,2023

Study describes how insulinomas, a rare type of pancreatic beta cell tumor, form

byUniversitat Pompeu Fabra - BarcelonaClose-up of insulinoma cells expressing insulin (red). Credit: Pompeu Fabra University (UPF)A study led by Pompeu Fabra University describes the mechanism w

Updated on: July 05,2024

Study describes how insulinomas, a rare type of pancreatic beta cell tumor, form

byUniversitat Pompeu Fabra - BarcelonaClose-up of insulinoma cells expressing insulin (red). Credit: Pompeu Fabra University (UPF)A study led by Pompeu Fabra University describes the mechanism w

Updated on:July 05,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

New method for noninvasive detection of circulating tumor cells in blood

bySPIEThe dual-ratio (DR) diffuse in-vivo flow cytometry (DiFC) is a novel technique that uses two laser sources and two detectors to mitigate the effects of noise and autofluorescence, which ma

Updated on: January 10,2024

New method for noninvasive detection of circulating tumor cells in blood

bySPIEThe dual-ratio (DR) diffuse in-vivo flow cytometry (DiFC) is a novel technique that uses two laser sources and two detectors to mitigate the effects of noise and autofluorescence, which ma

Updated on:January 10,2024